A Case–Control Study of Smoking and Bladder Cancer Risk: Emergent Patterns Over Time

Background Cigarette smoking is a well-established risk factor for bladder cancer. The effects of smoking duration, intensity (cigarettes per day), and total exposure (pack-years); smoking cessation; exposure to environmental tobacco smoke; and changes in the composition of tobacco and cigarette des...

Full description

Saved in:
Bibliographic Details
Published inJNCI : Journal of the National Cancer Institute Vol. 101; no. 22; pp. 1553 - 1561
Main Authors Baris, Dalsu, Karagas, Margaret R., Verrill, Castine, Johnson, Alison, Andrew, Angeline S., Marsit, Carmen J., Schwenn, Molly, Colt, Joanne S., Cherala, Sai, Samanic, Claudine, Waddell, Richard, Cantor, Kenneth P., Schned, Alan, Rothman, Nathaniel, Lubin, Jay, Fraumeni, Joseph F., Hoover, Robert N., Kelsey, Karl T., Silverman, Debra T.
Format Journal Article
LanguageEnglish
Published Cary, NC Oxford University Press 18.11.2009
Oxford Publishing Limited (England)
Subjects
Online AccessGet full text
ISSN0027-8874
1460-2105
1460-2105
DOI10.1093/jnci/djp361

Cover

Loading…
Abstract Background Cigarette smoking is a well-established risk factor for bladder cancer. The effects of smoking duration, intensity (cigarettes per day), and total exposure (pack-years); smoking cessation; exposure to environmental tobacco smoke; and changes in the composition of tobacco and cigarette design over time on risk of bladder cancer are unclear. Methods We examined bladder cancer risk in relation to smoking practices based on interview data from a large, population-based case–control study conducted in Maine, New Hampshire, and Vermont from 2001 to 2004 (N = 1170 urothelial carcinoma case patients and 1413 control subjects). We calculated odds ratios (ORs) and 95% confidence intervals (CIs) using unconditional logistic regression. To examine changes in smoking-induced bladder cancer risk over time, we compared odds ratios from New Hampshire residents in this study (305 case patients and 335 control subjects) with those from two case–control studies conducted in New Hampshire in 1994–1998 and in 1998–2001 (843 case patients and 1183 control subjects). Results Regular and current cigarette smokers had higher risks of bladder cancer than never-smokers (for regular smokers, OR = 3.0, 95% CI = 2.4 to 3.6; for current smokers, OR = 5.2, 95% CI = 4.0 to 6.6). In New Hampshire, there was a statistically significant increasing trend in smoking-related bladder cancer risk over three consecutive periods (1994–1998, 1998–2001, and 2002–2004) among former smokers (OR = 1.4, 95% CI = 1.0 to 2.0; OR = 2.0, 95% CI = 1.4 to 2.9; and OR = 2.6, 95% CI = 1.7 to 4.0, respectively) and current smokers (OR = 2.9, 95% CI = 2.0 to 4.2; OR = 4.2, 95% CI = 2.8 to 6.3; OR = 5.5, 95% CI = 3.5 to 8.9, respectively) (P for homogeneity of trends over time periods = .04). We also observed that within categories of intensity, odds ratios increased approximately linearly with increasing pack-years smoked, but the slope of the increasing trend declined with increasing intensity. Conclusions Smoking-related risks of bladder cancer appear to have increased in New Hampshire since the mid-1990s. Based on our modeling of pack-years and intensity, smoking fewer cigarettes over a long time appears more harmful than smoking more cigarettes over a shorter time, for equal total pack-years of cigarettes smoked.
AbstractList Cigarette smoking is a well-established risk factor for bladder cancer. The effects of smoking duration, intensity (cigarettes per day), and total exposure (pack-years); smoking cessation; exposure to environmental tobacco smoke; and changes in the composition of tobacco and cigarette design over time on risk of bladder cancer are unclear.BACKGROUNDCigarette smoking is a well-established risk factor for bladder cancer. The effects of smoking duration, intensity (cigarettes per day), and total exposure (pack-years); smoking cessation; exposure to environmental tobacco smoke; and changes in the composition of tobacco and cigarette design over time on risk of bladder cancer are unclear.We examined bladder cancer risk in relation to smoking practices based on interview data from a large, population-based case-control study conducted in Maine, New Hampshire, and Vermont from 2001 to 2004 (N = 1170 urothelial carcinoma case patients and 1413 control subjects). We calculated odds ratios (ORs) and 95% confidence intervals (CIs) using unconditional logistic regression. To examine changes in smoking-induced bladder cancer risk over time, we compared odds ratios from New Hampshire residents in this study (305 case patients and 335 control subjects) with those from two case-control studies conducted in New Hampshire in 1994-1998 and in 1998-2001 (843 case patients and 1183 control subjects).METHODSWe examined bladder cancer risk in relation to smoking practices based on interview data from a large, population-based case-control study conducted in Maine, New Hampshire, and Vermont from 2001 to 2004 (N = 1170 urothelial carcinoma case patients and 1413 control subjects). We calculated odds ratios (ORs) and 95% confidence intervals (CIs) using unconditional logistic regression. To examine changes in smoking-induced bladder cancer risk over time, we compared odds ratios from New Hampshire residents in this study (305 case patients and 335 control subjects) with those from two case-control studies conducted in New Hampshire in 1994-1998 and in 1998-2001 (843 case patients and 1183 control subjects).Regular and current cigarette smokers had higher risks of bladder cancer than never-smokers (for regular smokers, OR = 3.0, 95% CI = 2.4 to 3.6; for current smokers, OR = 5.2, 95% CI = 4.0 to 6.6). In New Hampshire, there was a statistically significant increasing trend in smoking-related bladder cancer risk over three consecutive periods (1994-1998, 1998-2001, and 2002-2004) among former smokers (OR = 1.4, 95% CI = 1.0 to 2.0; OR = 2.0, 95% CI = 1.4 to 2.9; and OR = 2.6, 95% CI = 1.7 to 4.0, respectively) and current smokers (OR = 2.9, 95% CI = 2.0 to 4.2; OR = 4.2, 95% CI = 2.8 to 6.3; OR = 5.5, 95% CI = 3.5 to 8.9, respectively) (P for homogeneity of trends over time periods = .04). We also observed that within categories of intensity, odds ratios increased approximately linearly with increasing pack-years smoked, but the slope of the increasing trend declined with increasing intensity.RESULTSRegular and current cigarette smokers had higher risks of bladder cancer than never-smokers (for regular smokers, OR = 3.0, 95% CI = 2.4 to 3.6; for current smokers, OR = 5.2, 95% CI = 4.0 to 6.6). In New Hampshire, there was a statistically significant increasing trend in smoking-related bladder cancer risk over three consecutive periods (1994-1998, 1998-2001, and 2002-2004) among former smokers (OR = 1.4, 95% CI = 1.0 to 2.0; OR = 2.0, 95% CI = 1.4 to 2.9; and OR = 2.6, 95% CI = 1.7 to 4.0, respectively) and current smokers (OR = 2.9, 95% CI = 2.0 to 4.2; OR = 4.2, 95% CI = 2.8 to 6.3; OR = 5.5, 95% CI = 3.5 to 8.9, respectively) (P for homogeneity of trends over time periods = .04). We also observed that within categories of intensity, odds ratios increased approximately linearly with increasing pack-years smoked, but the slope of the increasing trend declined with increasing intensity.Smoking-related risks of bladder cancer appear to have increased in New Hampshire since the mid-1990s. Based on our modeling of pack-years and intensity, smoking fewer cigarettes over a long time appears more harmful than smoking more cigarettes over a shorter time, for equal total pack-years of cigarettes smoked.CONCLUSIONSSmoking-related risks of bladder cancer appear to have increased in New Hampshire since the mid-1990s. Based on our modeling of pack-years and intensity, smoking fewer cigarettes over a long time appears more harmful than smoking more cigarettes over a shorter time, for equal total pack-years of cigarettes smoked.
Cigarette smoking is a well-established risk factor for bladder cancer. The effects of smoking duration, intensity (cigarettes per day), and total exposure (pack-years); smoking cessation; exposure to environmental tobacco smoke; and changes in the composition of tobacco and cigarette design over time on risk of bladder cancer are unclear. Here, Baris et al examine bladder cancer risk in relation to smoking practices based on interview data from a large, population-based case-control study conducted in Maine, New Hampshire, and Vermont from 2001 to 2004. Their study results indicate that smoking-related risks of bladder cancer appear to have increased in New Hampshire since the mid-1990s. Based on their modeling of pack-years and intensity, smoking fewer cigarettes over a long time appears more harmful than smoking more cigarettes over a shorter time, for equal total pack-years of cigarettes smoked.
Cigarette smoking is a well-established risk factor for bladder cancer. The effects of smoking duration, intensity (cigarettes per day), and total exposure (pack-years); smoking cessation; exposure to environmental tobacco smoke; and changes in the composition of tobacco and cigarette design over time on risk of bladder cancer are unclear. We examined bladder cancer risk in relation to smoking practices based on interview data from a large, population-based case-control study conducted in Maine, New Hampshire, and Vermont from 2001 to 2004 (N = 1170 urothelial carcinoma case patients and 1413 control subjects). We calculated odds ratios (ORs) and 95% confidence intervals (CIs) using unconditional logistic regression. To examine changes in smoking-induced bladder cancer risk over time, we compared odds ratios from New Hampshire residents in this study (305 case patients and 335 control subjects) with those from two case-control studies conducted in New Hampshire in 1994-1998 and in 1998-2001 (843 case patients and 1183 control subjects). Regular and current cigarette smokers had higher risks of bladder cancer than never-smokers (for regular smokers, OR = 3.0, 95% CI = 2.4 to 3.6; for current smokers, OR = 5.2, 95% CI = 4.0 to 6.6). In New Hampshire, there was a statistically significant increasing trend in smoking-related bladder cancer risk over three consecutive periods (1994-1998, 1998-2001, and 2002-2004) among former smokers (OR = 1.4, 95% CI = 1.0 to 2.0; OR = 2.0, 95% CI = 1.4 to 2.9; and OR = 2.6, 95% CI = 1.7 to 4.0, respectively) and current smokers (OR = 2.9, 95% CI = 2.0 to 4.2; OR = 4.2, 95% CI = 2.8 to 6.3; OR = 5.5, 95% CI = 3.5 to 8.9, respectively) (P for homogeneity of trends over time periods = .04). We also observed that within categories of intensity, odds ratios increased approximately linearly with increasing pack-years smoked, but the slope of the increasing trend declined with increasing intensity. Smoking-related risks of bladder cancer appear to have increased in New Hampshire since the mid-1990s. Based on our modeling of pack-years and intensity, smoking fewer cigarettes over a long time appears more harmful than smoking more cigarettes over a shorter time, for equal total pack-years of cigarettes smoked.
Background Cigarette smoking is a well-established risk factor for bladder cancer. The effects of smoking duration, intensity (cigarettes per day), and total exposure (pack-years); smoking cessation; exposure to environmental tobacco smoke; and changes in the composition of tobacco and cigarette design over time on risk of bladder cancer are unclear. Methods We examined bladder cancer risk in relation to smoking practices based on interview data from a large, population-based case–control study conducted in Maine, New Hampshire, and Vermont from 2001 to 2004 (N = 1170 urothelial carcinoma case patients and 1413 control subjects). We calculated odds ratios (ORs) and 95% confidence intervals (CIs) using unconditional logistic regression. To examine changes in smoking-induced bladder cancer risk over time, we compared odds ratios from New Hampshire residents in this study (305 case patients and 335 control subjects) with those from two case–control studies conducted in New Hampshire in 1994–1998 and in 1998–2001 (843 case patients and 1183 control subjects). Results Regular and current cigarette smokers had higher risks of bladder cancer than never-smokers (for regular smokers, OR = 3.0, 95% CI = 2.4 to 3.6; for current smokers, OR = 5.2, 95% CI = 4.0 to 6.6). In New Hampshire, there was a statistically significant increasing trend in smoking-related bladder cancer risk over three consecutive periods (1994–1998, 1998–2001, and 2002–2004) among former smokers (OR = 1.4, 95% CI = 1.0 to 2.0; OR = 2.0, 95% CI = 1.4 to 2.9; and OR = 2.6, 95% CI = 1.7 to 4.0, respectively) and current smokers (OR = 2.9, 95% CI = 2.0 to 4.2; OR = 4.2, 95% CI = 2.8 to 6.3; OR = 5.5, 95% CI = 3.5 to 8.9, respectively) (P for homogeneity of trends over time periods = .04). We also observed that within categories of intensity, odds ratios increased approximately linearly with increasing pack-years smoked, but the slope of the increasing trend declined with increasing intensity. Conclusions Smoking-related risks of bladder cancer appear to have increased in New Hampshire since the mid-1990s. Based on our modeling of pack-years and intensity, smoking fewer cigarettes over a long time appears more harmful than smoking more cigarettes over a shorter time, for equal total pack-years of cigarettes smoked.
Background Cigarette smoking is a well-established risk factor for bladder cancer. The effects of smoking duration, intensity (cigarettes per day), and total exposure (pack-years); smoking cessation; exposure to environmental tobacco smoke; and changes in the composition of tobacco and cigarette design over time on risk of bladder cancer are unclear. Methods We examined bladder cancer risk in relation to smoking practices based on interview data from a large, population-based case-control study conducted in Maine, New Hampshire, and Vermont from 2001 to 2004 (N = 1170 urothelial carcinoma case patients and 1413 control subjects). We calculated odds ratios (ORs) and 95% confidence intervals (CIs) using unconditional logistic regression. To examine changes in smoking-induced bladder cancer risk over time, we compared odds ratios from New Hampshire residents in this study (305 case patients and 335 control subjects) with those from two case-control studies conducted in New Hampshire in 1994-1998 and in 1998-2001 (843 case patients and 1183 control subjects). Results Regular and current cigarette smokers had higher risks of bladder cancer than never-smokers (for regular smokers, OR = 3.0, 95% CI = 2.4 to 3.6; for current smokers, OR = 5.2, 95% CI = 4.0 to 6.6). In New Hampshire, there was a statistically significant increasing trend in smoking-related bladder cancer risk over three consecutive periods (1994-1998, 1998-2001, and 2002-2004) among former smokers (OR = 1.4, 95% CI = 1.0 to 2.0; OR = 2.0, 95% CI = 1.4 to 2.9; and OR = 2.6, 95% CI = 1.7 to 4.0, respectively) and current smokers (OR = 2.9, 95% CI = 2.0 to 4.2; OR = 4.2, 95% CI = 2.8 to 6.3; OR = 5.5, 95% CI = 3.5 to 8.9, respectively) (P for homogeneity of trends over time periods = .04). We also observed that within categories of intensity, odds ratios increased approximately linearly with increasing pack-years smoked, but the slope of the increasing trend declined with increasing intensity. Conclusions Smoking-related risks of bladder cancer appear to have increased in New Hampshire since the mid-1990s. Based on our modeling of pack-years and intensity, smoking fewer cigarettes over a long time appears more harmful than smoking more cigarettes over a shorter time, for equal total pack-years of cigarettes smoked.
Author Fraumeni, Joseph F.
Johnson, Alison
Waddell, Richard
Schned, Alan
Kelsey, Karl T.
Silverman, Debra T.
Cherala, Sai
Verrill, Castine
Schwenn, Molly
Andrew, Angeline S.
Lubin, Jay
Colt, Joanne S.
Samanic, Claudine
Baris, Dalsu
Rothman, Nathaniel
Hoover, Robert N.
Karagas, Margaret R.
Marsit, Carmen J.
Cantor, Kenneth P.
AuthorAffiliation Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ)
AuthorAffiliation_xml – name: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ)
Author_xml – sequence: 1
  givenname: Dalsu
  surname: Baris
  fullname: Baris, Dalsu
  email: barisd@mail.nih.gov
  organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ)
– sequence: 2
  givenname: Margaret R.
  surname: Karagas
  fullname: Karagas, Margaret R.
  organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ)
– sequence: 3
  givenname: Castine
  surname: Verrill
  fullname: Verrill, Castine
  organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ)
– sequence: 4
  givenname: Alison
  surname: Johnson
  fullname: Johnson, Alison
  organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ)
– sequence: 5
  givenname: Angeline S.
  surname: Andrew
  fullname: Andrew, Angeline S.
  organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ)
– sequence: 6
  givenname: Carmen J.
  surname: Marsit
  fullname: Marsit, Carmen J.
  organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ)
– sequence: 7
  givenname: Molly
  surname: Schwenn
  fullname: Schwenn, Molly
  organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ)
– sequence: 8
  givenname: Joanne S.
  surname: Colt
  fullname: Colt, Joanne S.
  organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ)
– sequence: 9
  givenname: Sai
  surname: Cherala
  fullname: Cherala, Sai
  organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ)
– sequence: 10
  givenname: Claudine
  surname: Samanic
  fullname: Samanic, Claudine
  organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ)
– sequence: 11
  givenname: Richard
  surname: Waddell
  fullname: Waddell, Richard
  organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ)
– sequence: 12
  givenname: Kenneth P.
  surname: Cantor
  fullname: Cantor, Kenneth P.
  organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ)
– sequence: 13
  givenname: Alan
  surname: Schned
  fullname: Schned, Alan
  organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ)
– sequence: 14
  givenname: Nathaniel
  surname: Rothman
  fullname: Rothman, Nathaniel
  organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ)
– sequence: 15
  givenname: Jay
  surname: Lubin
  fullname: Lubin, Jay
  organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ)
– sequence: 16
  givenname: Joseph F.
  surname: Fraumeni
  fullname: Fraumeni, Joseph F.
  organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ)
– sequence: 17
  givenname: Robert N.
  surname: Hoover
  fullname: Hoover, Robert N.
  organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ)
– sequence: 18
  givenname: Karl T.
  surname: Kelsey
  fullname: Kelsey, Karl T.
  organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ)
– sequence: 19
  givenname: Debra T.
  surname: Silverman
  fullname: Silverman, Debra T.
  organization: Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD (DB, JSC, KPC, NR, CS, JL, JFF, RNH, DTS); Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH (MRK, ASA, RW, AS); Department of Community Health and Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island (CJM, KTK); Maine Cancer Registry, Augusta, ME (CV, MS); New Hampshire Cancer Registry, Concord, NH (SC); Vermont Cancer Registry, Burlington, VT (AJ)
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22174367$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19917915$$D View this record in MEDLINE/PubMed
BookMark eNqFksFu1DAQhi1URLctJ-4oQgIOVVrbceyEA1JZtRRUqYUtqOrF8trO4t3EXmynojfegTfkSfAqywKVUOcyh_nm169_ZgdsWWc1AE8QPECwLg7nVppDNV8WFD0AI0QozDGC5RYYQYhZXlWMbIOdEOYwVY3JI7CN6hqxGpUj8PkoG4ugf37_MXY2etdmk9ir28w12aRzC2NnmbAqe9MKpbRPrJWpfTRh8So77rSfaRuzCxGj9jZk5zdpeGk6vQceNqIN-vG674JPJ8eX49P87Pztu_HRWS5LymJeIUkLopkoKlJQxWgjp7qEmrK6rgjEihAJGSpJoWBJsERCUooaMiVSKqXKYhe8HnSX_bTTSiY3XrR86U0n_C13wvB_J9Z84TN3wzFjFWUoCbxcC3j3tdch8s4EqdtWWO36wKuUVAERw_eSrCCIlFUNE_nsDjl3vbcpB44xrCuG6cr507-dbyz_Pk0Cnq8BEaRoG5-iN2HDYYxYyowlbn_gpHcheN38kYJ89SB89SB8eJBEozu0NFFEszq-MO1_dl4MO65f3iOeD6AJUX_boMIveDLKSn56dc0n9D27uL76kAL7BazT21w
CODEN JNCIEQ
CitedBy_id crossref_primary_10_1016_j_tox_2019_152325
crossref_primary_10_1097_EDE_0000000000000964
crossref_primary_10_1093_carcin_bgq223
crossref_primary_10_1289_EHP9895
crossref_primary_10_1158_1055_9965_EPI_20_1045
crossref_primary_10_1002_cncr_28397
crossref_primary_10_1016_j_canep_2022_102233
crossref_primary_10_1590_s1677_5538_ibju_2018_0068
crossref_primary_10_16899_jcm_758091
crossref_primary_10_1016_j_hoc_2021_02_001
crossref_primary_10_1097_MOU_0b013e32833dde0d
crossref_primary_10_1016_j_urology_2020_12_033
crossref_primary_10_4132_KoreanJPathol_2011_45_1_62
crossref_primary_10_1016_j_afju_2018_11_008
crossref_primary_10_1016_j_ebiom_2018_10_051
crossref_primary_10_1002_ijc_26245
crossref_primary_10_1016_j_tox_2018_02_008
crossref_primary_10_1016_j_urology_2015_12_032
crossref_primary_10_1007_s13277_015_4566_9
crossref_primary_10_1111_j_1742_1241_2011_02763_x
crossref_primary_10_1080_17512433_2023_2219446
crossref_primary_10_2217_epi_2023_0358
crossref_primary_10_1260_2040_2295_3_4_535
crossref_primary_10_1016_j_jprot_2013_04_024
crossref_primary_10_1016_j_juro_2013_01_024
crossref_primary_10_3390_ijerph15040569
crossref_primary_10_1371_journal_pone_0091147
crossref_primary_10_1158_0008_5472_CAN_12_2388
crossref_primary_10_1053_j_ajkd_2011_01_017
crossref_primary_10_1016_j_acuroe_2013_02_008
crossref_primary_10_1016_j_clgc_2024_102296
crossref_primary_10_1111_j_1464_410X_2011_10371_x
crossref_primary_10_4254_wjh_v7_i7_942
crossref_primary_10_1158_1078_0432_CCR_20_4419
crossref_primary_10_1016_j_tox_2021_152801
crossref_primary_10_1007_s00394_022_02932_w
crossref_primary_10_1667_RR2841_1
crossref_primary_10_1111_ijun_12387
crossref_primary_10_1007_s11596_013_1218_4
crossref_primary_10_1111_ijcp_12143
crossref_primary_10_1002_ijc_28325
crossref_primary_10_1093_carcin_bgq178
crossref_primary_10_1097_CEJ_0000000000000404
crossref_primary_10_1007_s12561_023_09404_7
crossref_primary_10_1155_2012_101850
crossref_primary_10_1002_ijc_27590
crossref_primary_10_1158_1055_9965_EPI_10_0823
crossref_primary_10_1111_bju_15640
crossref_primary_10_1007_s10552_011_9792_x
crossref_primary_10_1007_s11255_022_03173_w
crossref_primary_10_1620_tjem_239_9
crossref_primary_10_1016_j_urology_2010_10_032
crossref_primary_10_1016_j_urology_2011_06_055
crossref_primary_10_1016_j_cancergencyto_2010_07_135
crossref_primary_10_1007_s10552_011_9788_6
crossref_primary_10_5402_2012_283670
crossref_primary_10_1093_jnci_djw099
crossref_primary_10_1016_j_urolonc_2012_09_001
crossref_primary_10_1016_j_oraloncology_2019_05_006
crossref_primary_10_1007_s13300_015_0128_9
crossref_primary_10_4236_health_2011_310103
crossref_primary_10_1007_s10552_017_0885_z
crossref_primary_10_1158_1055_9965_EPI_23_0331
crossref_primary_10_1016_j_urology_2011_08_072
crossref_primary_10_1002_ajim_22328
crossref_primary_10_1016_j_acuro_2013_02_004
crossref_primary_10_1093_ije_dyv175
crossref_primary_10_1111_ijcp_12127
crossref_primary_10_1002_ijc_33486
crossref_primary_10_7314_APJCP_2013_14_8_4553
crossref_primary_10_1002_cncr_28915
crossref_primary_10_1007_s00420_016_1182_y
crossref_primary_10_1007_s11356_013_1716_8
crossref_primary_10_2217_fon_12_180
crossref_primary_10_1016_j_eururo_2016_04_009
crossref_primary_10_1293_tox_2013_0039
crossref_primary_10_1016_j_toxlet_2020_11_005
crossref_primary_10_3389_fonc_2023_1126897
crossref_primary_10_1111_bju_12032
crossref_primary_10_3390_curroncol30020154
crossref_primary_10_1016_j_tox_2013_11_002
crossref_primary_10_1136_bmjopen_2011_000084
crossref_primary_10_1097_CCO_0b013e3283446a11
crossref_primary_10_3233_BLC_170111
crossref_primary_10_1093_jnci_djv223
crossref_primary_10_1158_1055_9965_EPI_11_1030
crossref_primary_10_1007_s00216_014_8080_5
crossref_primary_10_1038_s41370_024_00651_4
crossref_primary_10_1016_j_eururo_2011_03_027
crossref_primary_10_1371_journal_pone_0186214
crossref_primary_10_1186_s13148_022_01234_6
crossref_primary_10_1155_2013_986023
crossref_primary_10_1002_sim_9527
crossref_primary_10_1097_EDE_0000000000001112
crossref_primary_10_1200_JCO_2011_36_6518
crossref_primary_10_1097_MOU_0000000000000453
crossref_primary_10_1158_0008_5472_CAN_11_1154
crossref_primary_10_1093_ije_dyw044
crossref_primary_10_1007_s10147_011_0363_7
crossref_primary_10_1214_13_AOAS665
crossref_primary_10_1007_s10552_019_01161_7
crossref_primary_10_1007_s11934_014_0416_3
crossref_primary_10_1016_j_ijsu_2011_05_003
crossref_primary_10_1038_bjc_2012_187
crossref_primary_10_1158_1055_9965_EPI_12_0261
crossref_primary_10_1289_ehp_1002345
crossref_primary_10_1093_aje_kwu324
crossref_primary_10_1007_s00117_022_00992_x
crossref_primary_10_1016_j_yrtph_2016_06_012
crossref_primary_10_1111_j_1464_410X_2010_09874_x
crossref_primary_10_1177_0960327117734623
crossref_primary_10_1002_lt_22247
crossref_primary_10_1289_EHP89
crossref_primary_10_1007_s10552_014_0416_0
crossref_primary_10_1080_08958378_2018_1448019
crossref_primary_10_1158_1940_6207_CAPR_18_0441
crossref_primary_10_1371_journal_pone_0012334
crossref_primary_10_1093_carcin_bgu064
crossref_primary_10_1158_1055_9965_EPI_22_0801
crossref_primary_10_1016_S0084_4071_10_79512_9
crossref_primary_10_1093_jnci_djp385
crossref_primary_10_1177_2051415820947239
crossref_primary_10_1111_ijcp_12075
Cites_doi 10.1021/ac60273a017
10.1093/jat/30.3.187
10.1097/EDE.0b013e31812717fe
10.1023/A:1013954932343
10.1158/1055-9965.EPI-05-0863
10.1093/acprof:oso/9780195149616.003.0058
10.1093/aje/kwk047
10.1158/1055-9965.EPI-06-0021
10.1093/ije/dym043
10.1111/j.1464-410X.1994.tb07120.x
10.1093/aje/kwm392
10.1006/pmed.1997.0183
10.1002/ijc.11020
10.1056/NEJM199905063401810
10.1021/tx980005y
10.1023/A:1018453104303
10.1002/ijc.21183
10.1038/bjc.1985.106
10.1002/ijc.2910440411
10.1158/0008-5472.CAN-07-0048
10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M
10.1093/jnci/93.7.538
10.1002/(SICI)1097-0142(19970801)80:3<382::AID-CNCR5>3.0.CO;2-U
10.1002/rcm.1161
10.1023/B:CACO.0000036452.55199.a3
10.1007/s10552-006-0068-9
10.1158/1055-9965.EPI-04-0468
10.1093/acprof:oso/9780199566655.003.0006
10.1002/1097-0142(19860115)57:2<362::AID-CNCR2820570229>3.0.CO;2-F
10.1002/ijc.22169
10.1021/tx000260u
10.1038/bjc.1997.287
10.1093/aje/kwm089
10.1158/1055-9965.EPI-08-0613
10.1007/s00345-003-0382-8
10.1007/s002130051027
10.1093/jnci/90.19.1486
10.1093/jat/3.4.150
ContentType Journal Article
Copyright Published by Oxford University Press 2009. 2009
2015 INIST-CNRS
Copyright Oxford Publishing Limited(England) Nov 18, 2009
Copyright_xml – notice: Published by Oxford University Press 2009. 2009
– notice: 2015 INIST-CNRS
– notice: Copyright Oxford Publishing Limited(England) Nov 18, 2009
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7TO
7U7
7U9
C1K
H94
K9.
NAPCQ
7X8
7U1
5PM
DOI 10.1093/jnci/djp361
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Oncogenes and Growth Factors Abstracts
Toxicology Abstracts
Virology and AIDS Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
Risk Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Nursing & Allied Health Premium
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
Toxicology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Environmental Sciences and Pollution Management
MEDLINE - Academic
Risk Abstracts
DatabaseTitleList MEDLINE - Academic
Nursing & Allied Health Premium
MEDLINE


Risk Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1460-2105
EndPage 1561
ExternalDocumentID PMC2778671
1914779611
19917915
22174367
10_1093_jnci_djp361
10.1093/jnci/djp361
ark_67375_HXZ_S6J7PZXQ_7
Genre Journal Article
Research Support, N.I.H., Intramural
Research Support, N.I.H., Extramural
Feature
GeographicLocations United States
North America
America
Vermont
Maine
New Hampshire
USA, Maine
USA, New Hampshire
USA, Vermont
GeographicLocations_xml – name: Vermont
– name: New Hampshire
– name: Maine
– name: USA, New Hampshire
– name: USA, Maine
– name: USA, Vermont
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA57494
– fundername: NCI NIH HHS
  grantid: R01 CA057494
– fundername: NCI NIH HHS
  grantid: R01 CA121147
– fundername: Intramural NIH HHS
– fundername: NCI NIH HHS
  grantid: CA121147
– fundername: NIEHS NIH HHS
  grantid: P42 ES007373
GroupedDBID ---
-DD
-E4
-~X
.2P
.55
.GJ
.I3
.XZ
.ZR
08P
0R~
186
1TH
29L
2QL
2WC
354
3O-
4.4
482
48X
53G
5GY
5RE
5VS
5WD
70D
8WZ
96U
A6W
AABZA
AACZT
AAGKA
AAHTB
AAJKP
AAJQQ
AAKAS
AAMVS
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
AAWDT
AAWTL
ABCQX
ABDFA
ABEFU
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABNGD
ABNHQ
ABNKS
ABOCM
ABPEJ
ABPMR
ABPPZ
ABPTD
ABQLI
ABQNK
ABSMQ
ABVGC
ABXVV
ABZBJ
ACBMB
ACFRR
ACGFO
ACGFS
ACGOD
ACKOT
ACNCT
ACPQN
ACPRK
ACUFI
ACUKT
ACUTJ
ACUTO
ACVCV
ACYHN
ACZBC
ADBBV
ADEYI
ADEZT
ADGZP
ADHKW
ADHZD
ADIPN
ADMTO
ADNBA
ADOCK
ADQBN
ADRTK
ADVEK
ADXHL
ADYVW
ADZCM
AEGPL
AEHUL
AEJOX
AEKPW
AEKSI
AEMDU
AEMQT
AENZO
AEPUE
AETBJ
AETEA
AEWNT
AFAZI
AFCHL
AFFNX
AFFQV
AFFZL
AFIYH
AFOFC
AFRAH
AFSHK
AFXAL
AFYAG
AGINJ
AGKEF
AGKRT
AGMDO
AGNAY
AGORE
AGQPQ
AGSYK
AGUTN
AHGBF
AHMBA
AHMMS
AHXPO
AI.
AIAGR
AIJHB
AJBYB
AJDVS
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APJGH
APWMN
AQDSO
AQKUS
ASPBG
ATGXG
ATTQO
AVNTJ
AVWKF
AZFZN
BAWUL
BAYMD
BCRHZ
BEYMZ
BKOMP
BSCLL
BTRTY
BVRKM
BZKNY
C45
CAG
CDBKE
COF
CS3
CZ4
DAKXR
DIK
DILTD
DU5
D~K
E3Z
EBS
EE~
EIHJH
EJD
EMOBN
ENERS
F5P
F8P
F9B
FA8
FECEO
FEDTE
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GOZPB
GRPMH
GX1
H13
H5~
HAR
HVGLF
HW0
HZ~
IH2
IOX
J21
J5H
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
LXL
LXN
LXY
M-Z
MBLQV
MHKGH
ML0
MVM
N9A
NGC
NOMLY
NOYVH
NTWIH
NU-
NVLIB
O0~
OAUYM
OAWHX
OBFPC
OBH
OCB
OCZFY
ODMLO
ODZKP
OGEVE
OHH
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
O~Y
P2P
PAFKI
PB-
PEELM
PQQKQ
Q.-
Q1.
Q5Y
QBD
R44
RD5
RNI
RNS
ROL
ROX
ROZ
RUSNO
RW1
RXO
RZF
RZO
TCURE
TEORI
TJX
TMA
TR2
TWZ
UDS
UPT
VH1
VVN
W8F
WH7
WOQ
X7H
X7M
XJT
Y6R
YAYTL
YHZ
YKOAZ
YQT
YR5
YXANX
ZKX
ZRR
ZY1
~91
~H1
~X8
AASNB
ABQTQ
ADJQC
ADRIX
ADZXQ
M49
RHF
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
VXZ
7TO
7U7
7U9
C1K
H94
K9.
NAPCQ
7X8
7U1
5PM
ID FETCH-LOGICAL-c567t-81c634e7a38436d76fcbe50e67998402d44c071543d0542c1ac661f4b4ccddd53
ISSN 0027-8874
1460-2105
IngestDate Thu Aug 21 18:18:38 EDT 2025
Fri Jul 11 04:57:13 EDT 2025
Fri Jul 11 08:35:12 EDT 2025
Mon Jun 30 10:51:06 EDT 2025
Wed Feb 19 01:47:24 EST 2025
Mon Jul 21 09:16:21 EDT 2025
Thu Apr 24 23:09:31 EDT 2025
Tue Jul 01 01:42:08 EDT 2025
Wed Sep 11 04:51:28 EDT 2024
Tue Aug 05 16:47:46 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 22
Keywords Human
Urinary system disease
Tobacco smoking
Urinary tract disease
Malignant tumor
Case control study
Bladder cancer
Epidemiology
Urology
Cancerology
Risk factor
Bladder disease
Public health
Cancer
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c567t-81c634e7a38436d76fcbe50e67998402d44c071543d0542c1ac661f4b4ccddd53
Notes istex:42D610D81F29699A23EFDBEA3D41DACB7DE02861
ark:/67375/HXZ-S6J7PZXQ-7
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
PMID 19917915
PQID 220987265
PQPubID 41605
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2778671
proquest_miscellaneous_899130172
proquest_miscellaneous_734145890
proquest_journals_220987265
pubmed_primary_19917915
pascalfrancis_primary_22174367
crossref_primary_10_1093_jnci_djp361
crossref_citationtrail_10_1093_jnci_djp361
oup_primary_10_1093_jnci_djp361
istex_primary_ark_67375_HXZ_S6J7PZXQ_7
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-11-18
PublicationDateYYYYMMDD 2009-11-18
PublicationDate_xml – month: 11
  year: 2009
  text: 2009-11-18
  day: 18
PublicationDecade 2000
PublicationPlace Cary, NC
PublicationPlace_xml – name: Cary, NC
– name: United States
– name: Oxford
PublicationTitle JNCI : Journal of the National Cancer Institute
PublicationTitleAlternate J Natl Cancer Inst
PublicationYear 2009
Publisher Oxford University Press
Oxford Publishing Limited (England)
Publisher_xml – name: Oxford University Press
– name: Oxford Publishing Limited (England)
References Lubin ( key 20170702081950_bib22) 2006; 15
Karagas ( key 20170702081950_bib23) 2004; 15
Wynder ( key 20170702081950_bib33) 1998; 90
Samanic ( key 20170702081950_bib8) 2006; 15
Fortuny ( key 20170702081950_bib24) 2007; 7
Jones ( key 20170702081950_bib2) 1999; 340
Burns ( key 20170702081950_bib35)
Stellman ( key 20170702081950_bib34) 1997; 80
Sorahan ( key 20170702081950_bib12) 1994; 74
Alberg ( key 20170702081950_bib14) 2007; 165
Day ( key 20170702081950_bib43) 1980; 64
Vineis ( key 20170702081950_bib9) 2000; 463
Decarli ( key 20170702081950_bib36) 1985; 51
Lubin ( key 20170702081950_bib38) 2007; 36
Lubin ( key 20170702081950_bib42) 2007; 18
Brooks ( key 20170702081950_bib30) 2005; 14
Hoffmann ( key 20170702081950_bib20) 2001; 14
Lubin ( key 20170702081950_bib21) 2007; 166
Kabat ( key 20170702081950_bib17) 1986; 57
Jemal ( key 20170702081950_bib32) 2003; 105
Vineis ( key 20170702081950_bib40) 2001; 10
Brennan ( key 20170702081950_bib44) 2000; 86
Hartge ( key 20170702081950_bib10) 1987; 78
Zeegers ( key 20170702081950_bib16) 2002; 13
Scherer ( key 20170702081950_bib29) 1999; 145
Lubin ( key 20170702081950_bib37) 2008; 167
Sak ( key 20170702081950_bib39) 2007; 8
Law ( key 20170702081950_bib41) 1997; 75
Jiang ( key 20170702081950_bib13) 2007; 67
Benowitz ( key 20170702081950_bib28)
Bjerregaard ( key 20170702081950_bib45) 2006; 119
Hecht ( key 20170702081950_bib5) 1998; 11
Masuda ( key 20170702081950_bib27) 1969; 41
Hoffmann ( key 20170702081950_bib18)
Devesa ( key 20170702081950_bib31) 2005; 117
Vineis ( key 20170702081950_bib6) 1997; 8
Riedel ( key 20170702081950_bib4) 2006; 30
Hoffmann ( key 20170702081950_bib19) 1997; 26
Silverman ( key 20170702081950_bib1) 2006
Castelao ( key 20170702081950_bib11) 2001; 93
Burch ( key 20170702081950_bib47) 1989; 44
Bjerregaard ( key 20170702081950_bib15) 2006; 17
Patrianakos ( key 20170702081950_bib26) 1979; 3
Zeegers ( key 20170702081950_bib46) 2004; 21
Skipper ( key 20170702081950_bib7) 2003; 12
Peppone ( key 20170702081950_bib25)
Van Hemelrijck ( key 20170702081950_bib48) 2009; 18
Stabbert ( key 20170702081950_bib3) 2003; 17
14685762 - World J Urol. 2004 Feb;21(6):392-401
5788023 - Anal Chem. 1969 Apr;41(4):650-2
2793235 - Int J Cancer. 1989 Oct 15;44(4):622-8
9245661 - Prev Med. 1997 Jul-Aug;26(4):427-34
9625726 - Chem Res Toxicol. 1998 Jun;11(6):559-603
15767332 - Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):576-81
18250081 - Am J Epidemiol. 2008 Apr 15;167(8):970-5
19917914 - J Natl Cancer Inst. 2009 Nov 18;101(22):1525-6
17700253 - Epidemiology. 2007 Sep;18(5):639-48
3942969 - Cancer. 1986 Jan 15;57(2):362-7
16894557 - Int J Cancer. 2006 Nov 15;119(10):2412-6
17510079 - Int J Epidemiol. 2007 Feb;36(1):236-41
3473252 - J Natl Cancer Inst. 1987 Jun;78(6):1119-25
19880815 - J Natl Cancer Inst. 2009 Nov 18;101(22):1532-4
17111263 - Cancer Causes Control. 2006 Dec;17(10):1305-9
16835335 - Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1348-54
11751441 - Cancer Epidemiol Biomarkers Prev. 2001 Dec;10(12):1249-52
9184188 - Br J Cancer. 1997;75(11):1690-3
6929006 - J Natl Cancer Inst. 1980 Apr;64(4):977-89
11287448 - J Natl Cancer Inst. 2001 Apr 4;93(7):538-45
12955743 - Rapid Commun Mass Spectrom. 2003;17(18):2125-32
9776415 - J Natl Cancer Inst. 1998 Oct 7;90(19):1486-8
10445368 - Psychopharmacology (Berl). 1999 Jul;145(1):1-20
10228196 - N Engl J Med. 1999 May 6;340(18):1424-6
15900604 - Int J Cancer. 2005 Nov 1;117(2):294-9
16803653 - J Anal Toxicol. 2006 Apr;30(3):187-95
17204516 - Am J Epidemiol. 2007 Mar 15;165(6):660-6
19336562 - Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1312-20
17425776 - BMC Genet. 2007;8:13
10738259 - Int J Cancer. 2000 Apr 15;86(2):289-94
10928863 - Mutat Res. 2000 Jul;463(1):103-10
7827847 - Br J Urol. 1994 Dec;74(6):753-6
16537710 - Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):517-23
17548786 - Am J Epidemiol. 2007 Aug 15;166(4):479-89
12814994 - Cancer Epidemiol Biomarkers Prev. 2003 Jun;12(6):503-7
12672038 - Int J Cancer. 2003 May 20;105(1):101-7
17692123 - BMC Urol. 2007;7:13
9241071 - Cancer. 1997 Aug 1;80(3):382-8
15286466 - Cancer Causes Control. 2004 Jun;15(5):465-72
9498898 - Cancer Causes Control. 1997 May;8(3):346-55
17671226 - Cancer Res. 2007 Aug 1;67(15):7540-5
11453723 - Chem Res Toxicol. 2001 Jul;14(7):767-90
3994914 - Br J Cancer. 1985 May;51(5):707-12
11899922 - Cancer Causes Control. 2002 Feb;13(1):83-90
References_xml – volume: 41
  start-page: 650
  issue: 4
  year: 1969
  ident: key 20170702081950_bib27
  article-title: Quantitative determination of 1-naphthylamine and 2-naphthylamine in cigarette smoke
  publication-title: Anal Chem.
  doi: 10.1021/ac60273a017
– volume: 30
  start-page: 187
  issue: 3
  year: 2006
  ident: key 20170702081950_bib4
  article-title: Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokers
  publication-title: J Anal Toxicol
  doi: 10.1093/jat/30.3.187
– volume: 18
  start-page: 639
  issue: 5
  year: 2007
  ident: key 20170702081950_bib42
  article-title: Cigarette smoking and lung cancer: modeling effect modification of total exposure and intensity
  publication-title: Epidemiology
  doi: 10.1097/EDE.0b013e31812717fe
– volume: 13
  start-page: 83
  issue: 1
  year: 2002
  ident: key 20170702081950_bib16
  article-title: A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands)
  publication-title: Cancer Causes Control
  doi: 10.1023/A:1013954932343
– volume: 15
  start-page: 517
  issue: 3
  year: 2006
  ident: key 20170702081950_bib22
  article-title: Cigarette smoking and lung cancer: modeling total exposure and intensity
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-05-0863
– start-page: 1101
  volume-title: Cancer Epidemiology and Prevention
  year: 2006
  ident: key 20170702081950_bib1
  article-title: Bladder cancer
  doi: 10.1093/acprof:oso/9780195149616.003.0058
– volume: 165
  start-page: 660
  issue: 6
  year: 2007
  ident: key 20170702081950_bib14
  article-title: A prospective cohort study of bladder cancer risk in relation to active cigarette smoking and household exposure to secondhand cigarette smoke
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwk047
– volume: 15
  start-page: 1348
  issue: 7
  year: 2006
  ident: key 20170702081950_bib8
  article-title: Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-06-0021
– volume: 36
  start-page: 236
  issue: 1
  year: 2007
  ident: key 20170702081950_bib38
  article-title: Evidence for an intensity-dependent interaction of NAT2 acetylation genotype and cigarette smoking in the Spanish Bladder Cancer Study
  publication-title: Int J Epidemiol
  doi: 10.1093/ije/dym043
– volume: 74
  start-page: 753
  issue: 6
  year: 1994
  ident: key 20170702081950_bib12
  article-title: Urothelial cancer and cigarette smoking: findings from a regional case-controlled study
  publication-title: Br J Urol
  doi: 10.1111/j.1464-410X.1994.tb07120.x
– volume: 167
  start-page: 970
  issue: 8
  year: 2008
  ident: key 20170702081950_bib37
  article-title: Cigarette smoking and cancer: intensity patterns in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study in Finnish men
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwm392
– volume: 26
  start-page: 427
  issue: 4
  year: 1997
  ident: key 20170702081950_bib19
  article-title: The changing cigarette
  publication-title: Prev Med
  doi: 10.1006/pmed.1997.0183
– volume: 105
  start-page: 101
  issue: 1
  year: 2003
  ident: key 20170702081950_bib32
  article-title: Lung cancer rates convergence in young men and women in the United States: analysis by birth cohort and histologic type
  publication-title: Int J Cancer
  doi: 10.1002/ijc.11020
– volume: 340
  start-page: 1424
  issue: 18
  year: 1999
  ident: key 20170702081950_bib2
  article-title: Prevention of bladder cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199905063401810
– volume: 8
  issue: 13
  year: 2007
  ident: key 20170702081950_bib39
  article-title: DNA repair gene XRCC1 polymorphisms and bladder cancer risk
  publication-title: BMC Genet.
– volume: 11
  start-page: 559
  issue: 6
  year: 1998
  ident: key 20170702081950_bib5
  article-title: Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines
  publication-title: Chem Res Toxicol
  doi: 10.1021/tx980005y
– volume: 8
  start-page: 346
  issue: 3
  year: 1997
  ident: key 20170702081950_bib6
  article-title: Aromatic amines and cancer
  publication-title: Cancer Causes Control
  doi: 10.1023/A:1018453104303
– volume: 117
  start-page: 294
  issue: 2
  year: 2005
  ident: key 20170702081950_bib31
  article-title: International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising
  publication-title: Int J Cancer
  doi: 10.1002/ijc.21183
– volume: 51
  start-page: 707
  issue: 5
  year: 1985
  ident: key 20170702081950_bib36
  article-title: Bladder cancer mortality of workers exposed to aromatic amines: analysis of models of carcinogenesis
  publication-title: Br J Cancer
  doi: 10.1038/bjc.1985.106
– volume: 44
  start-page: 622
  issue: 4
  year: 1989
  ident: key 20170702081950_bib47
  article-title: Risk of bladder cancer by source and type of tobacco exposure: a case-control study
  publication-title: Int J Cancer
  doi: 10.1002/ijc.2910440411
– ident: key 20170702081950_bib25
  article-title: Cigarette smoking, bladder cancer and change in risk over 40 years
  publication-title: Frontiers in Cancer Prevention Research Conference Proceedings
– volume: 67
  start-page: 7540
  issue: 15
  year: 2007
  ident: key 20170702081950_bib13
  article-title: Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-07-0048
– volume: 86
  start-page: 289
  issue: 2
  year: 2000
  ident: key 20170702081950_bib44
  article-title: Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies
  publication-title: Int J Cancer
  doi: 10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M
– volume: 463
  start-page: 103
  issue: 1
  year: 2000
  ident: key 20170702081950_bib9
  article-title: Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation
  publication-title: Mutat Res.
– volume: 93
  start-page: 538
  issue: 7
  year: 2001
  ident: key 20170702081950_bib11
  article-title: Gender- and smoking-related bladder cancer risk
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/93.7.538
– volume: 80
  start-page: 382
  issue: 3
  year: 1997
  ident: key 20170702081950_bib34
  article-title: Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking
  publication-title: Cancer
  doi: 10.1002/(SICI)1097-0142(19970801)80:3<382::AID-CNCR5>3.0.CO;2-U
– volume: 17
  start-page: 2125
  issue: 18
  year: 2003
  ident: key 20170702081950_bib3
  article-title: Analysis of aromatic amines in cigarette smoke
  publication-title: Rapid Commun Mass Spectrom
  doi: 10.1002/rcm.1161
– volume: 15
  start-page: 465
  issue: 5
  year: 2004
  ident: key 20170702081950_bib23
  article-title: Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire
  publication-title: Cancer Causes Control
  doi: 10.1023/B:CACO.0000036452.55199.a3
– volume: 17
  start-page: 1305
  issue: 10
  year: 2006
  ident: key 20170702081950_bib15
  article-title: The effect of occasional smoking on smoking-related cancers: in the European Prospective Investigation into Cancer and Nutrition (EPIC)
  publication-title: Cancer Causes Control
  doi: 10.1007/s10552-006-0068-9
– volume: 14
  start-page: 576
  issue: 3
  year: 2005
  ident: key 20170702081950_bib30
  article-title: Influence of type of cigarette on peripheral versus central lung cancer
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-04-0468
– volume-title: Risk Associated With Smoking Cigarettes With Low Machine-Measured Yields of Tar and Nicotine
  ident: key 20170702081950_bib18
  article-title: The changing cigarettes: chemical studies and bioassays
  doi: 10.1093/acprof:oso/9780199566655.003.0006
– volume: 57
  start-page: 362
  issue: 2
  year: 1986
  ident: key 20170702081950_bib17
  article-title: Bladder cancer in nonsmokers
  publication-title: Cancer
  doi: 10.1002/1097-0142(19860115)57:2<362::AID-CNCR2820570229>3.0.CO;2-F
– volume: 119
  start-page: 2412
  issue: 10
  year: 2006
  ident: key 20170702081950_bib45
  article-title: Tobacco smoke and bladder cancer–in the European Prospective Investigation into Cancer and Nutrition
  publication-title: Int J Cancer
  doi: 10.1002/ijc.22169
– volume: 10
  start-page: 1249
  issue: 12
  year: 2001
  ident: key 20170702081950_bib40
  article-title: Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 12
  start-page: 503
  issue: 6
  year: 2003
  ident: key 20170702081950_bib7
  article-title: Nonsmoking-related arylamine exposure and bladder cancer risk
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume-title: Risk Associated With Smoking Cigarettes With Low Machine-Measured Yields of Tar and Nicotine
  ident: key 20170702081950_bib28
  article-title: Compensatory smoking of low yields cigarettes
– volume: 78
  start-page: 1119
  issue: 6
  year: 1987
  ident: key 20170702081950_bib10
  article-title: Changing cigarette habits and bladder cancer risk: a case-control study
  publication-title: J Natl Cancer Inst
– volume-title: Risk Associated With Smoking Cigarettes With Low Machine-Measured Yields of Tar and Nicotine
  ident: key 20170702081950_bib35
  article-title: Smoking lower yield cigarettes and disease risk
– volume: 14
  start-page: 767
  issue: 7
  year: 2001
  ident: key 20170702081950_bib20
  article-title: The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder
  publication-title: Chem Res Toxicol
  doi: 10.1021/tx000260u
– volume: 75
  start-page: 1690
  issue: 11
  year: 1997
  ident: key 20170702081950_bib41
  article-title: The dose-response relationship between cigarette consumption, biochemical markers and risk of lung cancer
  publication-title: Br J Cancer
  doi: 10.1038/bjc.1997.287
– volume: 166
  start-page: 479
  issue: 4
  year: 2007
  ident: key 20170702081950_bib21
  article-title: Cigarette smoking and cancer risk: modeling total exposure and intensity
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwm089
– volume: 64
  start-page: 977
  issue: 4
  year: 1980
  ident: key 20170702081950_bib43
  article-title: Multistage models and primary prevention of cancer
  publication-title: J Natl Cancer Inst
– volume: 18
  start-page: 1312
  issue: 4
  year: 2009
  ident: key 20170702081950_bib48
  article-title: Secondhand smoking, 4-aminobiphenyl, and bladder cancer: two meta-analyses
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-08-0613
– volume: 21
  start-page: 392
  issue: 6
  year: 2004
  ident: key 20170702081950_bib46
  article-title: The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review
  publication-title: World J Urol
  doi: 10.1007/s00345-003-0382-8
– volume: 145
  start-page: 1
  issue: 1
  year: 1999
  ident: key 20170702081950_bib29
  article-title: Smoking behaviour and compensation: a review of the literature
  publication-title: Psychopharmacology ( Berl )
  doi: 10.1007/s002130051027
– volume: 90
  start-page: 1486
  issue: 19
  year: 1998
  ident: key 20170702081950_bib33
  article-title: Re: Cigarette smoking and the histopathology of lung cancer
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/90.19.1486
– volume: 7
  issue: 13
  year: 2007
  ident: key 20170702081950_bib24
  article-title: Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study
  publication-title: BMC Urol
– volume: 3
  start-page: 150
  issue: 4
  year: 1979
  ident: key 20170702081950_bib26
  article-title: Chemical studies on tobacco smoke LXIV. On the analyses of aromatic amines in cigarettes smoke
  publication-title: J Anal Toxicol
  doi: 10.1093/jat/3.4.150
– reference: 15767332 - Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):576-81
– reference: 19336562 - Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1312-20
– reference: 17111263 - Cancer Causes Control. 2006 Dec;17(10):1305-9
– reference: 9625726 - Chem Res Toxicol. 1998 Jun;11(6):559-603
– reference: 18250081 - Am J Epidemiol. 2008 Apr 15;167(8):970-5
– reference: 17700253 - Epidemiology. 2007 Sep;18(5):639-48
– reference: 15286466 - Cancer Causes Control. 2004 Jun;15(5):465-72
– reference: 10445368 - Psychopharmacology (Berl). 1999 Jul;145(1):1-20
– reference: 11751441 - Cancer Epidemiol Biomarkers Prev. 2001 Dec;10(12):1249-52
– reference: 9776415 - J Natl Cancer Inst. 1998 Oct 7;90(19):1486-8
– reference: 5788023 - Anal Chem. 1969 Apr;41(4):650-2
– reference: 9184188 - Br J Cancer. 1997;75(11):1690-3
– reference: 16894557 - Int J Cancer. 2006 Nov 15;119(10):2412-6
– reference: 17692123 - BMC Urol. 2007;7:13
– reference: 16537710 - Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):517-23
– reference: 3473252 - J Natl Cancer Inst. 1987 Jun;78(6):1119-25
– reference: 17548786 - Am J Epidemiol. 2007 Aug 15;166(4):479-89
– reference: 11899922 - Cancer Causes Control. 2002 Feb;13(1):83-90
– reference: 19917914 - J Natl Cancer Inst. 2009 Nov 18;101(22):1525-6
– reference: 12672038 - Int J Cancer. 2003 May 20;105(1):101-7
– reference: 17425776 - BMC Genet. 2007;8:13
– reference: 11453723 - Chem Res Toxicol. 2001 Jul;14(7):767-90
– reference: 15900604 - Int J Cancer. 2005 Nov 1;117(2):294-9
– reference: 3942969 - Cancer. 1986 Jan 15;57(2):362-7
– reference: 16835335 - Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1348-54
– reference: 10228196 - N Engl J Med. 1999 May 6;340(18):1424-6
– reference: 16803653 - J Anal Toxicol. 2006 Apr;30(3):187-95
– reference: 3994914 - Br J Cancer. 1985 May;51(5):707-12
– reference: 17204516 - Am J Epidemiol. 2007 Mar 15;165(6):660-6
– reference: 9498898 - Cancer Causes Control. 1997 May;8(3):346-55
– reference: 17671226 - Cancer Res. 2007 Aug 1;67(15):7540-5
– reference: 11287448 - J Natl Cancer Inst. 2001 Apr 4;93(7):538-45
– reference: 6929006 - J Natl Cancer Inst. 1980 Apr;64(4):977-89
– reference: 14685762 - World J Urol. 2004 Feb;21(6):392-401
– reference: 12814994 - Cancer Epidemiol Biomarkers Prev. 2003 Jun;12(6):503-7
– reference: 10738259 - Int J Cancer. 2000 Apr 15;86(2):289-94
– reference: 12955743 - Rapid Commun Mass Spectrom. 2003;17(18):2125-32
– reference: 2793235 - Int J Cancer. 1989 Oct 15;44(4):622-8
– reference: 17510079 - Int J Epidemiol. 2007 Feb;36(1):236-41
– reference: 9245661 - Prev Med. 1997 Jul-Aug;26(4):427-34
– reference: 9241071 - Cancer. 1997 Aug 1;80(3):382-8
– reference: 10928863 - Mutat Res. 2000 Jul;463(1):103-10
– reference: 7827847 - Br J Urol. 1994 Dec;74(6):753-6
– reference: 19880815 - J Natl Cancer Inst. 2009 Nov 18;101(22):1532-4
SSID ssj0000924
Score 2.3713377
Snippet Background Cigarette smoking is a well-established risk factor for bladder cancer. The effects of smoking duration, intensity (cigarettes per day), and total...
Background Cigarette smoking is a well-established risk factor for bladder cancer. The effects of smoking duration, intensity (cigarettes per day), and total...
Cigarette smoking is a well-established risk factor for bladder cancer. The effects of smoking duration, intensity (cigarettes per day), and total exposure...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
oup
istex
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1553
SubjectTerms Adult
Aged
Biological and medical sciences
Bladder
Cancer
Case-Control Studies
Cigarettes
Female
Humans
Incidence
Maine - epidemiology
Male
Medical research
Medical sciences
Middle Aged
Nephrology. Urinary tract diseases
New Hampshire - epidemiology
Odds Ratio
Oncology
Risk Assessment
Risk Factors
Smoking
Smoking - adverse effects
Smoking - epidemiology
Smoking Cessation
Tumors
Tumors of the urinary system
Urinary Bladder Neoplasms - epidemiology
Urinary Bladder Neoplasms - etiology
Urinary tract. Prostate gland
Vermont - epidemiology
Title A Case–Control Study of Smoking and Bladder Cancer Risk: Emergent Patterns Over Time
URI https://api.istex.fr/ark:/67375/HXZ-S6J7PZXQ-7/fulltext.pdf
https://www.ncbi.nlm.nih.gov/pubmed/19917915
https://www.proquest.com/docview/220987265
https://www.proquest.com/docview/734145890
https://www.proquest.com/docview/899130172
https://pubmed.ncbi.nlm.nih.gov/PMC2778671
Volume 101
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKJiEkhLiOMhh-mHhgCkvjW8tbVS5j0iYQHar2EjmOA-ySVk0rIcSP55zYSZqpQ8BLW8WuXeX7fHrsfOccQnY1ZyZFzZPSNgrAv82CRGUiYDYTWmZM6bIYzNGxPDjhhxMx6XR-rUaXLJJX5ufauJL_QRWuAa4YJfsPyNaDwgX4DPjCKyAMr3-F8XDPwJ9QUMnNiypBdHE5Pa-CD5MLtC1zVHcZeEMpeVmNx4VdLjCxKp4JFnuo5SxLzbf81ePRh_LUYMVxLWWR1RniyA1baw6ak9G5y17wBu7Csjbreq6_uhCyqsJuo1j8gkki3VOQkYbhmgf-voyXC8hB-VPrrGKAQXvevFpnX7kMA9hlipYB9scZjmkuTNnbU6xqtNbQuyRYZ7lBkNKzGXMp3VdAn12WqKO0Sw1cyOiVzNpV0w2yGcEmA836-0kjEApha-ojOmG2fZxr381UZpp13225M5u4Mn9UoZK3Z7qAdZa5AinrdjBXhbgrns34LrnjkaVDx697pGPz--TmkRddPCDjIV2lGS1pRqcZ9TSjQDPqaUYdzSjS7DWtSEYrklEkGUWSPSQn796ORweBL8YRGCHVIuj3jGTcKs36nMlUycwkVoRWKtiw8zBKOTfgrgrOUtgFRKanDbh-GU-4MWmaCvaIbOTT3D4mdJCFRiZ96C8kt4wlPXTabY9HSgiRqi55Wd3T2PhM9Vgw5SJ2igkWIxaxw6JLduvOM5egZX23FyU4dR89P0dNoxLxweQ0_iwP1cfTyacYJn8O6P15qJ0WsnXfqNzeSxhiu4I69taigMZw0FeRFF1C61Yw5fh8Tud2uixiBR4lF_1BeH2XPtCO4bFNl2w56jS_1DOyS1SLVHUHTCTfbsm_fysTykeYRFL1nlw75ja51Sznp2RjMV_aZ-CML5Kdcs38BuJc4sA
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+case-control+study+of+smoking+and+bladder+cancer+risk%3A+emergent+patterns+over+time&rft.jtitle=JNCI+%3A+Journal+of+the+National+Cancer+Institute&rft.au=Baris%2C+Dalsu&rft.au=Karagas%2C+Margaret+R&rft.au=Verrill%2C+Castine&rft.au=Johnson%2C+Alison&rft.date=2009-11-18&rft.eissn=1460-2105&rft.volume=101&rft.issue=22&rft.spage=1553&rft_id=info:doi/10.1093%2Fjnci%2Fdjp361&rft_id=info%3Apmid%2F19917915&rft.externalDocID=19917915
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0027-8874&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0027-8874&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0027-8874&client=summon